Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Huabao Flavours & Fragrances Co., Ltd. (300741.SZ)
Lhasa, CN
Huabao Flavours & Fragrances Co., Ltd. operates globally, specializing in the research, development, production, sale, and service of a wide range of products including tobacco, food, and daily chemical flavors, as well as specialized food ingredients. Serving both domestic and international markets, the company's food flavorings are extensively utilized in dairy products, beverages, frozen desserts, baked goods, confectionery, various nuts, betel nuts, spices, instant noodles, meat products, snack foods, and catering. Furthermore, its food ingredient division provides natural and healthy components for application in food and beverages, health care, nutritional supplements, and personal care items. These products are marketed under a portfolio of brands such such as Huabao, H&K, Tianhong, HEDON, Hua Fang, Owada, and Amber. Established in 1996 as Huabao Food Flavours & Fragrances (Shanghai) Co., Ltd., the company adopted its current name, Huabao Flavours & Fragrances Co., Ltd., in 2016. It is headquartered in Lhasa, China, and operates as a subsidiary of Huafeng International Investment Holdings (China) Co., Ltd.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.19% | -2.35% | +0.12% | -11.76% | -10.57% | -10.71% | +1.16% | -23.65% | -58.40% | -70.15% | -70.15% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-2.0% Q1'26: +13.6% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+129.2% ★ Q1'26: -9.5% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-4.5% Q1'26: -4.0% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+0.1% Q1'26: +9.6% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+0.0% Q1'26: +4.9% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-0.2% ★ Q1'26: +1.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.76× ★ Q1'26: 0.42× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2.17B
est: 2.39B (-9.1%)
|
2.19B
est: 2.27B (-3.6%)
|
2.09B
est: 2.24B (-6.3%)
|
1.94B
est: 2.39B (-18.9%)
|
1.89B
est: 2.61B (-27.4%)
|
1.48B
est: 2.61B (-43.1%)
|
2.39B
2.39B – 2.39B
-8.5% YoY
|
2.27B
2.27B – 2.27B
-5.0% YoY
|
2.24B
2.24B – 2.24B
-1.4% YoY
|
2.39B
2.39B – 2.39B
+7.0% YoY
|
2.61B
2.61B – 2.61B
+8.9% YoY
|
| EBITDA |
1.16B
est: 845.08M (+37.2%)
|
1.18B
est: 803.21M (+46.9%)
|
1.14B
est: 791.88M (+44.2%)
|
954.76M
est: 847.48M (+12.7%)
|
699.66M
est: 923.27M (-24.2%)
|
373.55M
est: 923.27M (-59.5%)
|
615.13M
615.13M – 615.13M
-33.4% YoY
|
584.65M
584.65M – 584.65M
-5.0% YoY
|
576.40M
576.40M – 576.40M
-1.4% YoY
|
616.88M
616.88M – 616.88M
+7.0% YoY
|
672.04M
672.04M – 672.04M
+8.9% YoY
|
| EBIT |
1.12B
est: 775.29M (+44.9%)
|
1.15B
est: 736.88M (+55.5%)
|
1.11B
est: 726.48M (+52.5%)
|
921.20M
est: 777.49M (+18.5%)
|
648.03M
est: 847.02M (-23.5%)
|
311.97M
est: 847.02M (-63.2%)
|
523.42M
523.42M – 523.42M
-38.2% YoY
|
497.49M
497.49M – 497.49M
-5.0% YoY
|
490.47M
490.47M – 490.47M
-1.4% YoY
|
524.91M
524.91M – 524.91M
+7.0% YoY
|
571.85M
571.85M – 571.85M
+8.9% YoY
|
| Net Income |
1.18B
est: 1.27B (-7.1%)
|
1.24B
est: 1.24B (-0.5%)
|
1.18B
est: 1.28B (-8.1%)
|
1.00B
est: 1.37B (-26.7%)
|
724.93M
est: 1.49B (-51.5%)
|
378.99M
est: 1.49B (-74.6%)
|
1.26B
1.26B – 1.26B
-15.5% YoY
|
1.24B
1.24B – 1.24B
-2.0% YoY
|
1.28B
1.28B – 1.28B
+3.5% YoY
|
1.37B
1.37B – 1.37B
+6.7% YoY
|
1.49B
1.49B – 1.49B
+9.0% YoY
|
| SGA |
376.80M
est: 457.32M (-17.6%)
|
332.22M
est: 434.67M (-23.6%)
|
289.11M
est: 428.54M (-32.5%)
|
291.07M
est: 458.63M (-36.5%)
|
350.03M
est: 499.64M (-29.9%)
|
314.27M
est: 499.64M (-37.1%)
|
543.41M
543.41M – 543.41M
+8.8% YoY
|
516.49M
516.49M – 516.49M
-5.0% YoY
|
509.20M
509.20M – 509.20M
-1.4% YoY
|
544.96M
544.96M – 544.96M
+7.0% YoY
|
593.69M
593.69M – 593.69M
+8.9% YoY
|
| EPS |
1.94
est: 2.05 (-5.4%)
|
2.01
est: 2.01 (+0.0%)
|
1.92
est: 2.08 (-7.7%)
|
1.63
est: 2.22 (-26.6%)
|
1.18
est: 2.42 (-51.2%)
|
0.62
est: 2.42 (-74.4%)
|
2.05
2.05 – 2.05
-15.3% YoY
|
2.01
2.01 – 2.01
-2.0% YoY
|
2.08
2.08 – 2.08
+3.5% YoY
|
2.22
2.22 – 2.22
+6.7% YoY
|
2.42
2.42 – 2.42
+9.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-11 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-08 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-07 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-06 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-30 | B | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-29 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-28 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-27 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-24 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-23 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-22 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-21 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-20 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 1/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P Emerging Markets Small Cap ETF EWX | 0.01% | 73.0K | 0.65% |
| 2 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 68.6K | 0.39% |
| 3 | State Street SPDR S&P Emerging Asia Pacific ETF GMF | 0.00% | 3.2K | 0.49% |
| 4 | Dimensional - Emerging Markets Value ETF DFEV | 0.00% | 9.6K | 0.46% |
| 5 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 14.5K | 0.26% |
| 6 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 6.4K | 0.48% |
| 7 | Vanguard FTSE Emerging Markets ETF VWO | 0.00% | 716.1K | 0.06% |
| 8 | Vanguard FTSE Emerging Markets UCITS ETF (USD) Accumulating VFEA.L | 0.00% | 23.2K | 0.17% |
| 9 | Vanguard FTSE Emerging Markets UCITS ETF (USD) Distributing VDEM.L | 0.00% | 23.2K | 0.17% |
| 10 | Vanguard All-World ex-US Shares Index ETF VEU.AX | 0.00% | 6.3K | 0.04% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jie Zhang | Chief Financial Officer & Vice President | — | male |
| Miao Ren | Vice President & Non-Independent Director | — | male |
| Pengliang Han | Vice President & Non-Independent Director | — | male |
| Qiu Dong Yuan | Vice President | — | male |
| Xiao Qin Yuan | President & Director | — | female |
| Xiaojun Li | Vice President | — | female |
| Xiaoqin Hou | Vice President & Secretary of the Board of Directors | — | female |
| Yu Jin Ren | Head of Accounting | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 300741.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
